|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||19.29 - 19.96|
|52 Week Range||16.19 - 24.87|
|Beta (5Y Monthly)||0.75|
|PE Ratio (TTM)||26.91|
|Forward Dividend & Yield||0.43 (2.20%)|
|Ex-Dividend Date||Feb 12, 2020|
|1y Target Est||N/A|
Siemens Healthineers announced today that its latest critical care testing solution, the RAPIDPoint® 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration. The analyzer generates blood gas, electrolyte, metabolite, CO-oximetry, and neonatal bilirubin results, which are used to diagnose and monitor critically ill patients in the intensive care unit, operating room, or emergency room. Already available in countries requiring the CE mark, the RAPIDPoint 500e Blood Gas Analyzer is now available for critical care testing in the United States.
Today we'll take a closer look at Siemens Healthineers AG (ETR:SHL) from a dividend investor's perspective. Owning a...
Siemens Healthineers AG (ETR:SHL) stock is about to trade ex-dividend in 3 days time. You can purchase shares before...
NEW YORK, NY / ACCESSWIRE / February 3, 2020 / Siemens Healthineers AG (OTCMKTS:SMMNY) will be discussing their earnings results in their 2020 First Quarter Earnings to be held on February 3, 2020 at 8:00 ...
Siemens Healthineers (SHL.DE) announced today that it was selected by Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, to be its preferred supplier for immunoassay testing. When fully realized, this would be the largest deployment of the Atellica Solution worldwide to date and strengthens the medical technology company’s position as the market leader in the United States.
Passive investing in index funds can generate returns that roughly match the overall market. But one can do better...
Today we'll look at Siemens Healthineers AG (ETR:SHL) and reflect on its potential as an investment. Specifically...
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at...